Status:

RECRUITING

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Lead Sponsor:

Sardocor Corp.

Conditions:

Congestive Heart Failure

Heart Failure, Systolic

Eligibility:

All Genders

18-80 years

Phase:

PHASE1

PHASE2

Brief Summary

It is believed that targeted SERCA2a enzyme replacement in HFrEF patients will correct defective intracellular Ca2+ hemostasis, resulting in improved cardiac contractile function and energetics which ...

Detailed Description

MUSIC-HFrEF1 is an interventional study of SRD-001, an adeno-associated virus serotype 1 (AAV1) vector expressing the transgene for sarco(endo)plasmic reticulum Ca2+ ATPase 2a isoform (SERCA2a), in an...

Eligibility Criteria

Inclusion

  • Main
  • Chronic ischemic or non-ischemic cardiomyopathy
  • NYHA class III/IV
  • LVEF ≤35%
  • Guideline-directed medical therapy for heart failure; ICD
  • Main

Exclusion

  • Restrictive cardiomyopathy, hypertrophic cardiomyopathy, acute myocarditis, pericardial disease, amyloidosis, infiltrative cardiomyopathy, uncorrected thyroid disease or discrete left ventricular (LV) aneurysm
  • Prior heart transplantation, left ventricular reduction surgery (LVRS), cardiomyoplasty, passive restraint device (e.g., CorCap™ Cardiac Support Device), mechanical circulatory support device (MCSD) or cardiac shunt
  • Likely to receive cardiac resynchronization therapy, cardiomyoplasty, LVRS, conventional revascularization procedure or valvular repair in the 6 months following treatment
  • Likely need for an immediate heart transplant or MCSD implant due to hemodynamic instability
  • Inadequate hepatic and renal function
  • Diagnosis of, or treatment for, any cancer within the last 5 years except for basal cell carcinoma or carcinomas in situ where surgical excision was considered curative

Key Trial Info

Start Date :

September 23 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2028

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT04703842

Start Date

September 23 2021

End Date

December 1 2028

Last Update

March 26 2024

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

San Diego Cardiac Center

San Diego, California, United States, 92123

2

University of California, San Francisco

San Francisco, California, United States, 94143

3

Washington University in Saint Louis

St Louis, Missouri, United States, 63110

4

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390